WHO-PEN@Scale

Scaling up the WHO-PEN package for diabetes and hypertension in Swaziland: a nation-wide cluster-randomised evaluation of three strategies in Swaziland

Objective

The WHO-PEN@Scale project aims to improve diabetes and hypertension control at the population-level by helping Eswatini identify and scale up the most effective healthcare delivery model for WHO-PEN implementation at scale.


Description

Eswatini has a very high prevalence of both diabetes and hypertension, with the majority of those affected being undiagnosed. Like many other countries in sub-Saharan Africa (SSA), however, Eswatini provides care for diabetes and hypertension only through physician-led teams in hospitals. The country has recently conducted a successful feasibility pilot of the World Health Organisation’s Package of Essential NCD Interventions for Primary Health Care in low-resource settings (WHO-PEN).


AIGHD Research Lead

Prof. Ria Reis


Partners

University Hospital Heidelberg (coordinator) (Germany)

Swiss Tropical and Public Health Institute (Switzerland)

University of Swaziland (Eswatini)

Amsterdam Institute for Global Health and Development Foundation (Netherlands)

Georg August University of Göttingen Public Law Foundation (Germany)

Norwegian Institute of Public Health / FOLKEHELSEINSTITUTTET (Norway)

Clinton Health Access Initiative (United States)

Diabetes Swaziland (Eswatini)

Swaziland Business Coalition on HIV and AIDS (Eswatini)


Contact info

Mark van Knegsel (m.vanknegsel@aighd.org)


Funders

EC – Horizon2020


Countries

Germany

Switzerland

Eswatini

Netherlands

Norway

United States